David Ryan, MD, explains the reasons for the current epidemic of esophageal cancer.
On Oct. 12, the Department of Medicine and the Cancer Center announced the appointment of David Ryan, MD, as the new chief of Hematology/Oncology at the MGH. Ryan, who succeeds Jose Baselga, MD, PhD, joined the MGH Cancer Center in 1998.
The MGH celebrated the creation of the John R. Gallagher III and Katherine A. Gallagher Endowed Chair in Gastrointestinal Cancer Research.
Efforts at Massachusetts General Hospital Cancer Center are underway to address the need for more effective treatment approaches for locally advanced and metastatic disease.
The MGH Cancer Center has received a $1.05 million gift from Sovereign Bank, N.A., a division of Santander Holdings USA, in support of its Hematology/Oncology Research Fellowship Fund.